1273 Results (Page 47 of 51)
Healthcare Services Markets Research Reports
Malaysia Genomics Market Analysis
The Malaysia Genomics market was valued at $52.5 Mn in 2023 and is predicted to grow at a CAGR of 16.70% from 2023 to 2030, to $154.7 Mn by 2030. The key drivers of the market include increasing incidence and prevalence of cancer, the need for advancements in cancer treatments, and the increasing trend of personalized medicines. The prominent players of the Malaysia genomics market are Malaysian Genomics Resource Centre, Codon Genomics, MyTACG Bioscience, Genesis Genome, and Genetics Healthcare Centre, among others.
Germany Patient Adherence Programs Market Analysis
The Germany Patient Adherence Programs Market was valued at $474.2 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $1,356.4 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players of the Germany Patient Adherence Programs Market are
Philippines Genomics Market Analysis
The Philippines Genomics market was valued at $71.8 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $215.6 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Philippines genomics market are PHIX Genomics, Philippine Genome Centre (PGC), Department of Science and Technology (DOST), Institute of Human Genetics (IHG), among others.
US Financial Assistance Programs Market Analysis
The US Financial Assistance Programs Market was valued at $11,902.5 Mn in 2023 and is projected to grow at a CAGR of 12.6% from 2023 to 2023, to $27,315.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
Singapore Genomics Market Analysis
The Singapore Genomics market was valued at $39.2 Mn in 2023 and is predicted to grow at a CAGR of 17.10% from 2023 to 2030, to $118.3 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Singapore genomics market are the Genome Institute of Singapore (GIS), NovogeneAIT Genomics, Molecular Genomics, and ACT Genomics, among others.
Saudi Arabia Financial Assistance Programs Market Analysis
The Saudi Arabia Financial Assistance Programs Market was valued at $481.8 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $1,369.8 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Takeda Pharmaceuticals, Teva Pharmaceuticals, GSK, Novartis among others.
South Africa Genomics Market Analysis
The South Africa Genomics market was valued at $212.2 Mn in 2023 and is predicted to grow at a CAGR of 17.73% from 2023 to 2030, to $665.3 Mn by 2030. The key drivers of the market include the need for advancements in cancer treatments, rising burden of Non-Communicable Diseases (NCDs), and increasing trend of personalized medicines. The prominent players of the South Africa Genomics Market are the South African National Bioinformatics Institute (SANBI), South African Medical Research Council (SAMRC), Illumina, Thermo Fisher Scientific, and Qiagen, among others.
UAE Financial Assistance Programs Market Analysis
The UAE Financial Assistance Programs Market was valued at $141.7 Mn in 2023 and is projected to grow at a CAGR of 15.6% from 2023 to 2023, to $390.9 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, Teva, Takeda, Merck, GSK, Johnson & Johnson, Novartis among others.
Brazil Financial Assistance Programs Market Analysis
The Brazil Financial Assistance Programs Market was valued at $708.5 Mn in 2023 and is projected to grow at a CAGR of 15.6% from 2023 to 2023, to $1,954.5 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, AbbVie, Merck, Sanofi, Johnson & Johnson, Novartis among others.
Mexico Financial Assistance Programs Market Analysis
The Mexico Financial Assistance Programs Market was valued at $425.1 Mn in 2023 and is projected to grow at a CAGR of 14.85% from 2023 to 2023, to $1,120.5 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Sanofi, AstraZeneca, AbbVie, Merck, GSK, Johnson & Johnson, Novartis among others.
France Financial Assistance Programs Market Analysis
The France Financial Assistance Programs Market was valued at $779.3 Mn in 2023 and is projected to grow at a CAGR of 13.6% from 2023 to 2023, to $1,902.7 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Pierre Fabre, Roche, Merck, GSK, Johnson & Johnson, Novartis among others.
Germany Financial Assistance Programs Market Analysis
The Germany Financial Assistance Programs Market was valued at $1,037.2 Mn in 2023 and is projected to grow at a CAGR of 12.8% from 2023 to 2023, to $2,410.1 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as B. Braun, Boehringer Ingelheim Merck, GSK, Johnson & Johnson, Novartis among others.
Spain Financial Assistance Programs Market Analysis
The Spain Financial Assistance Programs Market was valued at $546.9 Mn in 2023 and is projected to grow at a CAGR of 13.6% from 2023 to 2023, to $1,335.3 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
UK Financial Assistance Programs Market Analysis
The UK Financial Assistance Programs Market was valued at $736.8 Mn in 2023 and is projected to grow at a CAGR of 12.6% from 2023 to 2023, to $1,690.0 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Takeda, AstraZeneca, Bristol Meyer Squibb, Roche, GSK, among others.
China Financial Assistance Programs Market Analysis
The China Financial Assistance Programs Market was valued at $2,278.1 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $6,477.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as CSPC Pharmaceuticals, Cardinal Health, Sinopharm Group Co Ltd, Merck, GSK, Johnson & Johnson, Novartis among others.
Indonesia Financial Assistance Programs Market Analysis
The Indonesia Financial Assistance Programs Market was valued at $170 Mn in 2023 and is projected to grow at a CAGR of 14.6% from 2023 to 2023, to $441.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Mayer, Cipla, Merck, GSK, Johnson & Johnson, Novartis among others.
Japan Financial Assistance Programs Market Analysis
The Japan Financial Assistance Programs Market was valued at $1,761.5 Mn in 2023 and is projected to grow at a CAGR of 15.1% from 2023 to 2023, to $4,714.3 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Daiichi Sankyo Co Ltd, Takeda, Bayer, Baxter, GSK, Johnson & Johnson, Sanofi among others.
Malaysia Financial Assistance Programs Market Analysis
The Malaysia Financial Assistance Programs Market was valued at $45.6 Mn in 2023 and is projected to grow at a CAGR of 14.8% from 2023 to 2023, to $119.7 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, Johnson & Johnson, Novartis among others.
Singapore Financial Assistance Programs Market Analysis
The Singapore Financial Assistance Programs Market was valued at $34 Mn in 2023 and is projected to grow at a CAGR of 15.2% from 2023 to 2023, to $91.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, GSK among others.
Philippines Financial Assistance Programs Market Analysis
The Philippines Financial Assistance Programs Market was valued at $62.3 Mn in 2023 and is projected to grow at a CAGR of 15.1% from 2023 to 2023, to $166.9 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Sanofi, Pfizer, GSK, among others.
Vietnam Financial Assistance Programs Market Analysis
The Vietnam Financial Assistance Programs Market was valued at $141.7 Mn in 2023 and is projected to grow at a CAGR of 14.83% from 2023 to 2023, to $373 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
Egypt Financial Assistance Programs Market Analysis
The Egypt Financial Assistance Programs Market was valued at $79.3 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $225.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Roche, Pfizer, Bayer, Merck, GSK, Johnson & Johnson, Novartis among others.
Kenya Financial Assistance Programs Market Analysis
The Kenya Financial Assistance Programs Market was valued at $19.8 Mn in 2023 and is projected to grow at a CAGR of 15.7% from 2023 to 2023, to $55.1 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, AbbVie, Merck, GSK, Johnson & Johnson, Novartis among others.
Canada Radiology Service Market Analysis
The Canada Radiology Service Market was valued at $320 Mn in 2023 and is predicted to grow at a CAGR of 14.7% from 2023 to 2030, to $835.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Canada Radiology Service Market are The Ottawa Hospital, Vancouver General Hospital, St. Paul’s Hospital, Royal Alexandra Hospital, Foothills Medical Centre, and McGill University Health Centre, among others.
South Africa Financial Assistance Programs Market Analysis
The South Africa Financial Assistance Programs Market was valued at $184.2 Mn in 2023 and is projected to grow at a CAGR of 15.83% from 2023 to 2023, to $444.9 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.